"Well, I am very delighted to announce that we have sealed the deal on a new five-year strategic agreement with the federal government, which will commence at the conclusion of the current agreement on 1 July 2022," Medicines Australia CEO Liz de Somer told BioPharmaDispatch.
MA delighted at the agreement's 'really ambitious reform agenda'
September 7, 2021 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
It is profoundly wrong for any system to exclude compassion while outsourcing it to others
March 16, 2026 - - Latest News -
Scientists identify highly specific targets that could transform multiple myeloma treatment
March 15, 2026 - - Australian Biotech -
CSL Seqirus' adjuvanted flu vaccine approval extended to Australians aged 50 and over
March 15, 2026 - - Latest News -
GSK claims Pharma Cup as Kosi Challenge surpasses fundraising record
March 15, 2026 - - Latest News -
New program aims to make women’s health care more affordable and accessible
March 13, 2026 - - Latest News -
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News

